|
1
|
Okaji Y, Tsuno NH, Saito S, Yoneyama S,
Tanaka M, Nagawa H and Takahashi K: Vaccines targeting tumour
angiogenesis - a novel strategy for cancer immunotherapy. Eur J
Surg Oncol. 32:363–370. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boehm T, Folkman J, Browder T and O'Reilly
MS: Antiangiogenic therapy of experimental cancer does not induce
acquired drug resistance. Nature. 390:404–407. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dranoff G, Jaffee E, Lazenby A, Golumbek
P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D and Mulligan
RC: Vaccination with irradiated tumor cells engineered to secrete
murine granulocyte-macrophage colony-stimulating factor stimulates
potent, specific, and long-lasting anti-tumor immunity. Proc Natl
Acad Sci USA. 90:3539–3543. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu JY, Wei YQ, Yang L, Zhao X, Tian L,
Hou JM, Niu T, Liu F, Jiang Y, Hu B, et al: Immunotherapy of tumors
with vaccine based on quail homologous vascular endothelial growth
factor receptor-2. Blood. 102:1815–1823. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wei YQ, Wang QR, Zhao X, Yang L, Tian L,
Lu Y, Kang B, Lu CJ, Huang MJ, Lou YY, et al: Immunotherapy of
tumors with xenogeneic endothelial cells as a vaccine. Nat Med.
6:1160–1166. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen XY, Zhang W, Zhang W, Wu S, Bi F, Su
YJ, Tan XY, Liu JN and Zhang J: Vaccination with viable human
umbilical vein endothelial cells prevents metastatic tumors by
attack on tumor vasculature with both cellular and humoral
immunity. Clin Cancer Res. 12:5834–5840. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Okaji Y, Tsuno NH, Tanaka M, Yoneyama S,
Matsuhashi M, Kitayama J, Saito S, Nagura Y, Tsuchiya T, Yamada J,
et al: Pilot study of anti-angiogenic vaccine using fixed whole
endothelium in patients with progressive malignancy after failure
of conventional therapy. Eur J Cancer. 44:383–390. 2008. View Article : Google Scholar
|
|
8
|
Chang MW, Grillari J, Mayrhofer C,
Fortschegger K, Allmaier G, Marzban G, Katinger H and Voglauer R:
Comparison of early passage, senescent and hTERT immortalized
endothelial cells. Exp Cell Res. 309:121–136. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Böcker W, Yin Z, Drosse I, Haasters F,
Rossmann O, Wierer M, Popov C, Locher M, Mutschler W, Docheva D, et
al: Introducing a single-cell-derived human mesenchymal stem cell
line expressing hTERT after lentiviral gene transfer. J Cell Mol
Med. 12:1347–1359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Freedman DA and Folkman J: Maintenance of
G1 checkpoint controls in telomerase-immortalized endothelial
cells. Cell Cycle. 3:811–816. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bodnar AG, Ouellette M, Frolkis M, Holt
SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S and
Wright WE: Extension of life-span by introduction of telomerase
into normal human cells. Science. 279:349–352. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu J, Wang H, Bishop JM and Blackburn EH:
Telomerase extends the lifespan of virus-transformed human cells
without net telomere lengthening. Proc Natl Acad Sci USA.
96:3723–3728. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Anno K, Hayashi A, Takahashi T, Mitsui Y,
Ide T and Tahara H: Telomerase activation induces elongation of the
telomeric single-stranded overhang, but does not prevent chromosome
aberrations in human vascular endothelial cells. Biochem Biophys
Res Commun. 353:926–932. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Young AT, Lakey JR, Murray AG, Mullen JC
and Moore RB: In vitro senescence occurring in normal human
endothelial cells can be rescued by ectopic telomerase activity.
Transplant Proc. 35:2483–2485. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
von Zglinicki T: Oxidative stress shortens
telomeres. Trends Biochem Sci. 27:339–344. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang J, Chang E, Cherry AM, Bangs CD, Oei
Y, Bodnar A, Bronstein A, Chiu CP and Herron GS: Human endothelial
cell life extension by telomerase expression. J Biol Chem.
274:26141–26148. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang J, Nagavarapu U, Relloma K, Sjaastad
MD, Moss WC, Passaniti A and Herron GS: Telomerized human
microvasculature is functional in vivo. Nat Biotechnol. 19:219–224.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Y, Shen G, Nie W, Li Z, Sang Y, Zhang B
and Wei Y: Irradiated tumor cells of lipopolysaccharide stimulation
elicit an enhanced anti-tumor immunity. J Cancer Res Clin Oncol.
140:1815–1823. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao Z, Yao Y, Ding Z, Chen X, Xie K, Luo
Y, Zhang J, Chen X, Wu X, Xu J, et al: Antitumour immunity mediated
by mannan-modified adenovirus vectors expressing VE-cadherin.
Vaccine. 29:4218–4224. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou X, Li J, Wang Z, Chen Z, Qiu J, Zhang
Y, Wang W, Ma Y, Huang N, Cui K, et al: Cellular immunotherapy for
carcinoma using genetically modified EGFR-specific T lymphocytes.
Neoplasia. 15:544–553. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gupta S, Marcel N, Sarin A and
Shivashankar GV: Role of actin dependent nuclear deformation in
regulating early gene expression. PLoS One. 7:e530312012.
View Article : Google Scholar
|
|
22
|
Zhang C, Shan J, Lu J, Huang Y, Feng L,
Long D, Li S, Li Q and Li Y: Combination of rapamycin and IL-2 do
not affect antigen presentation ability of rat B cell and could
promote Tregs proliferation and inhibitory activity. Cell Immunol.
264:180–185. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Skabytska Y, Wölbing F, Günther C, Köberle
M, Kaesler S, Chen KM, Guenova E, Demircioglu D, Kempf WE, Volz T,
et al: Cutaneous innate immune sensing of Toll-like receptor 2–6
ligands suppresses T cell immunity by inducing myeloid-derived
suppressor cells. Immunity. 41:762–775. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Y, Zhao YJ, Zou QY, Zhang K, Wu YM,
Zhou C, Wang K and Zheng J: Preeclampsia does not alter vascular
growth and expression of CD31 and vascular endothelial cadherin in
human placentas. J Histochem Cytochem. 63:22–31. 2015. View Article : Google Scholar
|
|
25
|
Bürgler S, Gimeno A, Parente-Ribes A, Wang
D, Os A, Devereux S, Jebsen P, Bogen B, Tjønnfjord GE and Munthe
LA: Chronic lymphocytic leukemia cells express CD38 in response to
Th1 cell-derived IFN-γ by a T-bet-dependent mechanism. J Immunol.
194:827–835. 2015. View Article : Google Scholar
|
|
26
|
Lohoff M, Giaisi M, Köhler R, Casper B,
Krammer PH and Li-Weber M: Early growth response protein-1 (Egr-1)
is preferentially expressed in T helper type 2 (Th2) cells and is
involved in acute transcription of the Th2 cytokine interleukin-4.
J Biol Chem. 285:1643–1652. 2010. View Article : Google Scholar :
|
|
27
|
Mulligan JK and Young MR: Tumors induce
the formation of suppressor endothelial cells in vivo. Cancer
Immunol Immunother. 59:267–277. 2010. View Article : Google Scholar
|
|
28
|
Blank S, Deck C, Dreikhausen L, Weichert
W, Giese N, Falk C, Schmidt T and Ott K: Angiogenic and growth
factors in gastric cancer. J Surg Res. 194:420–429. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shatry A, Chirinos J, Gorin MA, Jones M
and Levy RB: Targeting Treg cells in situ: Emerging expansion
strategies for (CD4+CD25+) regulatory T
cells. Biol Blood Marrow Transplant. 15:1239–1243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fernández A, Oliver L, Alvarez R,
Fernández LE, Lee KP and Mesa C: Adjuvants and myeloid-derived
suppressor cells: Enemies or allies in therapeutic cancer
vaccination. Hum Vaccin Immunother. 10:3251–3260. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xing X, Gu X, Ma T and Ye H: Biglycan
up-regulated vascular endothelial growth factor (VEGF) expression
and promoted angiogenesis in colon cancer. Tumour Biol.
36:1773–1780. 2015. View Article : Google Scholar
|
|
32
|
Okaji Y, Tsuno NH, Kitayama J, Saito S,
Takahashi T, Kawai K, Yazawa K, Asakage M, Hori N, Watanabe T, et
al: Vaccination with autologous endothelium inhibits angiogenesis
and metastasis of colon cancer through autoimmunity. Cancer Sci.
95:85–90. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Toomer KH and Chen Z: Autoimmunity as a
double agent in tumor killing and cancer promotion. Front Immunol.
5:1162014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vierboom MP, Nijman HW, Offringa R, van
der Voort EI, van Hall T, van den Broek L, Fleuren GJ, Kenemans P,
Kast WM and Melief CJ: Tumor eradication by wild-type p53-specific
cytotoxic T lymphocytes. J Exp Med. 186:695–704. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen F, Zhuang X, Lin L, Yu P, Wang Y, Shi
Y, Hu G and Sun Y: New horizons in tumor microenvironment biology:
Challenges and opportunities. BMC Med. 13:452015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Koh BI and Kang Y: The pro-metastatic role
of bone marrow-derived cells: A focus on MSCs and regulatory T
cells. EMBO Rep. 13:412–422. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pacini S: Deterministic and stochastic
approaches in the clinical application of mesenchymal stromal cells
(MSCs). Front Cell Dev Biol. 2:502014. View Article : Google Scholar : PubMed/NCBI
|
